Comparing techniques for the identification of the MTHFR A1298C polymorphism

Journal of Biomolecular Techniques

Volumn 19, Issue 2, 2008, Pages 103-105

  de Alvarenga, Maria Paula Sanches ^a   Pavarino Bertelli, Érika Cristina ^a   Goloni Bertollo, Eny Maria ^a  

^a School of Medicine University of São José Do Rio Preto   (Brazil)

Author keywords

DNA sequence; Methylenetetrahydrofolate reductase; Restriction fragment length polymorphism

Indexed keywords

ENDODEOXYRIBONUCLEASE MBOII; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PRIMER DNA; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIOTECHNOLOGY; BRAZIL; COMPARATIVE STUDY; DNA SEQUENCE; EVALUATION; EXON; GENETICS; HUMAN; KIDNEY TRANSPLANTATION; METHODOLOGY; NUCLEOTIDE SEQUENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; AMINO ACID SUBSTITUTION; BASE SEQUENCE; BIOTECHNOLOGY; BRAZIL; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA PRIMERS; EXONS; HUMANS; KIDNEY TRANSPLANTATION; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 63449093874     PISSN: 15240215     EISSN: 19434731     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354:407-713.
2. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary artery disease. Am J Hum Genet. 1991;48:536-545.
3. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahy-drofolate reductase. Nat Genet. 1995;10:111-113.
4. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-172.
5. van der Put NM, Gabrëls F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044-1051.
6. Sibani S, Leclerc D, Weisberg I, Rozen R. The silent T1317C mutation of methylenetetrahydrofolate reductase should not interfere with MboII restriction isotyping of the reported A1298C mutation. Mol Genet Metab. 1999;68:512.
7. van der Put NJ, Blom HJ. Letter to Editor: Reply to Donnelly. Am J Hum Genet. 2000;66:744.
8. Yi P, Pogribny IP, James SJ. Multiplex PCR for simultaneous detection of 677 C>T and 1298 A>C polymorphisms in methylenetetrahydrofolate reductase gene for population studies of cancer risk. Cancer Lett. 2002;181:209.
9. Ranjith N, Pegoraro RJ, Rom L. Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction. Cardiovasc JS Afr. 2003;14:127-132.
10. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-174.
11. Pegaro RJ, Chokosi A, Rom L, Roberts C, Moodley J. Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia. Acta Obstet Gynecol Scand. 2004;83:449-454.